Literature DB >> 35428960

The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA).

Alberto E Ardon1, John E George2, Kapil Gupta3, Michael J O'Rourke4, Melinda S Seering5, Hanae K Tokita6, Sylvia H Wilson7, Tracy-Ann Moo6, Ingrid Lizarraga5, Sarah McLaughlin8, Roy A Greengrass8.   

Abstract

Although pectoralis (PECS) blocks are commonly used for breast surgery, recommendations regarding the efficacy of these blocks have thus far not been developed by any professional anesthesia society. Given the potential impact of PECS blocks on analgesia after outpatient breast surgery, The Society for Ambulatory Anesthesia (SAMBA) convened a task force to develop a practice advisory on the use of this analgesic technique. In this practice advisory, we compare the efficacy of PECS blocks with systemic analgesia, local infiltration anesthesia, and paravertebral blockade. Our objectives were to advise on two clinical questions. (1) Does PECS-1 and/or -2 blockade provide more effective analgesia for breast-conserving surgery than either systemic analgesics or surgeon-provided local infiltration anesthesia? (2) Does PECS-1 and/or -2 blockade provide equivalent analgesia for mastectomy compared with a paravertebral block (PVB)? Among patients undergoing breast-conserving surgery, PECS blocks moderately reduce postoperative opioid use, prolong time to analgesic rescue, and decrease postoperative pain scores when compared with systemic analgesics. SAMBA recommends the use of a PECS-1 or -2 blockade in the absence of systemic analgesia (Strength of Recommendation A). No evidence currently exists that strongly favors the use of PECS blocks over surgeon-performed local infiltration in this surgical population. SAMBA cannot recommend PECS blocks over surgical infiltration (Strength of Recommendation C). For patients undergoing a mastectomy, a PECS block may provide an opioid-sparing effect similar to that achieved with PVB; SAMBA recommends the use of a PECS block if a patient is unable to receive a PVB (Strength of Recommendation A).
© 2022. Society of Surgical Oncology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35428960     DOI: 10.1245/s10434-022-11724-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  44 in total

1.  Serratus plane block: a novel ultrasound-guided thoracic wall nerve block.

Authors:  R Blanco; T Parras; J G McDonnell; A Prats-Galino
Journal:  Anaesthesia       Date:  2013-08-07       Impact factor: 6.955

2.  The 'pecs block': a novel technique for providing analgesia after breast surgery.

Authors:  R Blanco
Journal:  Anaesthesia       Date:  2011-09       Impact factor: 6.955

3.  Prospective double blind randomized placebo-controlled clinical trial of the pectoral nerves (Pecs) block type II.

Authors:  Barbara Versyck; Geert-Jan van Geffen; Patrick Van Houwe
Journal:  J Clin Anesth       Date:  2017-04-19       Impact factor: 9.452

4.  Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery.

Authors:  R Blanco; M Fajardo; T Parras Maldonado
Journal:  Rev Esp Anestesiol Reanim       Date:  2012-08-29

5.  Pectoralis and Serratus Fascial Plane Blocks Each Provide Early Analgesic Benefits Following Ambulatory Breast Cancer Surgery: A Retrospective Propensity-Matched Cohort Study.

Authors:  Faraj W Abdallah; David MacLean; Caveh Madjdpour; Tulin Cil; Anuj Bhatia; Richard Brull
Journal:  Anesth Analg       Date:  2017-07       Impact factor: 5.108

6.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

7.  PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations.

Authors:  A Jacobs; A Lemoine; G P Joshi; M Van de Velde; F Bonnet
Journal:  Anaesthesia       Date:  2020-01-26       Impact factor: 6.955

8.  PECS II block is associated with lower incidence of chronic pain after breast surgery.

Authors:  Alessandro De Cassai; Claudio Bonanno; Ludovica Sandei; Francesco Finozzi; Michele Carron; Alberto Marchet
Journal:  Korean J Pain       Date:  2019-10-01

9.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  BMJ       Date:  2021-03-29

10.  Efficacy of Pectoral Nerve Block Type II for Breast-Conserving Surgery and Sentinel Lymph Node Biopsy: A Prospective Randomized Controlled Study.

Authors:  Doo-Hwan Kim; Sooyoung Kim; Chan Sik Kim; Sukyung Lee; In-Gyu Lee; Hee Jeong Kim; Jong-Hyuk Lee; Sung-Moon Jeong; Kyu Taek Choi
Journal:  Pain Res Manag       Date:  2018-05-15       Impact factor: 3.037

View more
  2 in total

1.  ASO Author Reflections: SAMBA's Practice Advisory for the Use of Pectoralis Blocks in Breast Surgery: Overview and Lingering Questions.

Authors:  Alberto E Ardon; John E George; Kapil Gupta; Michael J O'Rourke; Melinda S Seering; Hanae K Tokita; Sylvia H Wilson; Tracy-Ann Moo; Ingrid Lizarraga; Sarah McLaughlin; Roy A Greengrass
Journal:  Ann Surg Oncol       Date:  2022-04-12       Impact factor: 4.339

2.  Efficacy of PECS block in addition to multimodal analgesia for postoperative pain management in patients undergoing outpatient elective breast surgery: A retrospective study.

Authors:  Alberto A Uribe; Tristan E Weaver; Marco Echeverria-Villalobos; Luis Periel; Joshua Pasek; Juan Fiorda-Diaz; Marilly Palettas; Roman J Skoracki; Stephen J Poteet; Jarrett A Heard
Journal:  Front Med (Lausanne)       Date:  2022-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.